Pharma

nference said researchers can use the de-identified clinical data to develop new therapeutics and diagnostics.

The company announced a $200 million Series C round in January.

The company said the clearance will allow more pharma companies to use Tasso+ for decentralized clinical trials.

First Databank president Bob Katter discusses the FDB Vela electronic prescribing network and how it will give patients with more control over their prescriptions.

Joining with like-minded healthcare and technology pros can help develop skills in leadership to overcome new challenges, says Amy Chacko, past president of HIMSS New England Chapter.

Precision medicine is entering the mainstream, from genetic insights informing a range of specialties to primary care using pharmacogenomics, according to Dr. Joel Diamond of 2bPrecise.

The partnership will allow Withings' connected scales, blood pressure monitors and sleep-tracking mats to integrate with Medable's trial platform.

The toolkits are based on the Digital Medicine Society's Sensor Data Integrations project, which includes organizations like Amazon Web Services, Oracle, the Moffitt Cancer Center, Takeda and the U.S. Department of Veterans Affairs.

Birgit Bauer, a digital health and patient expert, explains her involvement in the Gravitate Health project's user advisory group by offering a perspective on meaningful patient engagement.